Table 3 Summary statistics for 48- and... | American Society of Hematology

Table 3

Summary statistics for 48- and 72-h NSAA data for each course of therapy

Trough time (h)	Cycle	Acceptable data				NSAA (IU/mL)		NSAA ≥0.10 IU/mL
		Patients		Samples		NSAA (IU/mL)		Patients		Samples
		No.	%	No.	%	Median	Range	No.	%	No.	%
48	1	50	90.9	155	72.4	0.715	<LOQ-2.884	50	100	151	97.4
48	2	25	58.1	28	56.0	0.654	<LOQ-1.294	23	92.0	26	92.9
48	3	29	90.6	37	88.1	0.551	0.099-1.429	28	96.6	36	97.3
48	4	16	66.7	24	70.6	0.418	0.080-1.635	16	100	23	95.8
48	≥5	12	75.0	19	51.4	0.669	<LOQ-1.114	10	83.3	16	84.2
48	All	52	94.5	263	69.8	0.645	<LOQ-2.884	52	100	252	95.8
72	1	50	90.9	86	79.6	0.251	0.043-1-612	49	98.0	73	84.9
72	2	19	57.6	19	57.6	0.248	<LOQ-0.873	15	78.9	15	78.9
72	3	18	90.0	18	90.0	0.163	0.030-0.741	16	88.9	16	88.9
72	4	7	53.8	7	53.8	0.475	<LOQ-0.622	6	85.7	6	85.7
72	≥5	11	78.6	18	62.1	0.245	0.087-0.717	10	90.9	15	83.3
72	All	52	94.5	148	72.9	0.248	<LOQ-1.612	52	100	125	84.5

Trough time (h)	Cycle	Acceptable data				NSAA (IU/mL)		NSAA ≥0.10 IU/mL
		Patients		Samples		NSAA (IU/mL)		Patients		Samples
		No.	%	No.	%	Median	Range	No.	%	No.	%
48	1	50	90.9	155	72.4	0.715	<LOQ-2.884	50	100	151	97.4
48	2	25	58.1	28	56.0	0.654	<LOQ-1.294	23	92.0	26	92.9
48	3	29	90.6	37	88.1	0.551	0.099-1.429	28	96.6	36	97.3
48	4	16	66.7	24	70.6	0.418	0.080-1.635	16	100	23	95.8
48	≥5	12	75.0	19	51.4	0.669	<LOQ-1.114	10	83.3	16	84.2
48	All	52	94.5	263	69.8	0.645	<LOQ-2.884	52	100	252	95.8
72	1	50	90.9	86	79.6	0.251	0.043-1-612	49	98.0	73	84.9
72	2	19	57.6	19	57.6	0.248	<LOQ-0.873	15	78.9	15	78.9
72	3	18	90.0	18	90.0	0.163	0.030-0.741	16	88.9	16	88.9
72	4	7	53.8	7	53.8	0.475	<LOQ-0.622	6	85.7	6	85.7
72	≥5	11	78.6	18	62.1	0.245	0.087-0.717	10	90.9	15	83.3
72	All	52	94.5	148	72.9	0.248	<LOQ-1.612	52	100	125	84.5

LOQ, limit of quantitation.